Increased levels of apolipoprotein D in cerebrospinal fluid and hippocampus of Alzheimer's patients

Journal of Neurochemistry

Volumn 71, Issue 4, 1998, Pages 1643-1650

  Terrisse, L ^a   Poirier, J ^b   Bertrand, P ^b   Merched, A ^c   Visvikis, S ^c   Siest, G ^c   Milne, R ^d   Rassart, E ^a  

^a UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c Centre du Medicament URA CNRS 597   (France)

^d UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Alzheimer's disease; Apolipoprotein D; Apolipoprotein E; Nerve regeneration; Neurodegeneration; Neurodisorders

Indexed keywords

APOLIPOPROTEIN D; APOLIPOPROTEIN E;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; INHERITANCE; MAJOR CLINICAL STUDY; MALE; NERVE REGENERATION; NEUROPATHOLOGY; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN FAMILY; RADIOIMMUNOASSAY;

HIPPOCAMPUS HIPPOCAMPUS;

EID: 0031658643     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1998.71041643.x     Document Type: Article

References (50)

1. Amouyel P., Vidal O., Launay J. M., and Laplanche J. L. (1994) The apolipoprotein E alleles as major susceptibility factors for Creutzfeldt-Jakob disease. Lancet 344, 1315-1318.
2. Balbin M., Freije J. M., Fueyo A., Sanchez L., and Lopez-Otin C. (1990) Apolipoprotein D is the major protein component in cyst fluid from women with human breast cystic disease. Biochem. J. 271, 803-807.
3. Blennow K., Hesse C., and Freaman P. (1994) Cerebrospinal fluid apolipoprotein E is reduced in Alzheimer's disease. Neuroreport 5, 2534-2536.
4. Boyles J. K., Zoellner C. D., Anderson L. J., Kosik L. M., Pitas R. E., Weisgraber K. H., Hui D. Y., Mahley R. W., Gebicke-Haerter P. J., Ignatus M. J., and Shooter E. M. (1989) A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve. J. Clin. Invest. 83, 1015-1031.
5. Boyles J. K., Notterpek L. M., and Anderson L. J. (1990) Accumulation of apolipoproteins in the regenerating and remyelinating mammalian peripheral nerve. Identification of apolipoprotein D, apolipoprotein A-IV, apolipoprotein E and apolipoprotein A-I. J. Biol. Chem. 265, 17805-17815.
6. Cabrai J. H. M., Atkins G. L., Sanchez L. M., Lopez-Boado Y. S., Lopez-Otin C., and Sawyer L. (1995) Arachidonic acid binds to apolipoprotein D: implications for the protein's function. FEBS Lett. 366, 53-56.
7. Camato R., Marcel Y. L., Milne R. W., Lussier-Cacan S., and Weech P. K. (1989) Protein polymorphism of a human plasma apolipoprotein D antigenic epitope. J. Lipid Res. 30, 865-875.
8. Carlsson J., Armstrong V., Reiber H., Felgenhauer K., and Seidel D. (1991) Clinical relevance of the quantification of apolipoprotein E in cerebrospinal fluid. Clin. Chim. Acta 196, 167-176.
9. Diedrich J. F., Minnigan H., and Carp R. I. (1991) Neuropathological changes in scrapie and Alzheimer's disease are associated with increased expression of apolipoprotein E and cathepsin D in astrocytes. J. Virol. 65, 4759-4768.
10. Dilley W. G., Haagensen D. E., Cox C. E., and Wells S. A. Jr. (1990) Immunologic and steroid binding properties of the GCDFP-24 protein isolated from human gross cystic disease fluid. Breast Cancer Res. Treat. 16, 253-260.
11. Drayna D., Fielding C., McLean J., Baer B., Castro G., Chen E., Comstock L., Henzel W., Kohr W., Wion K., and Lawn R. (1986) Cloning and expression of human apolipoprotein D cDNA. J. Biol. Chem. 261, 16535-16539.
12. Goodrum J. F., Bouldin T. W., Zhang S. H., Maeda N., and Popko B. (1995) Nerve regeneration and cholesterol reutilization occur in the absence of apolipoprotein E and A-I in mice. J. Neurochem. 64, 408-416.
13. Ikeda T., Sugiuchi H., Senba U., Shibuya Y., Uji Y., Okabe H., and Araki S. (1993) Preliminary findings on the variation of serum apolipoprotein levels in neural degenerative disorders. J. Clin. Lab. Anal. 7, 1-4.
14. Lambert J., Provost P., Marcel Y. L., and Rassart E. (1993) Structure of the human apolipoprotein D gene promoter region. Biochim. Biophys. Acta 1172, 190-192.
15. Lehtimaki T., Pirtila T., Mehta P., Wisniewski H., Frey H., and Nikkari T. (1995) Apolipoprotein E polymorphism and its influence on apoE concentrations in the cerebrospinal fluid in Finnish patients with Alzheimer's disease. Hum. Genet. 95, 39-42.
16. Lopez-Boado Y. S., Tolivia J., and Lopez-Otin C. (1994) Apolipoprotein D gene induction by retinoic acid is concomitant with growth arrest and cell differentiation in human breast cancer cells. J. Biol. Chem. 269, 26871-26878.
17. Mahley R. W. (1988) Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240, 622-630.
18. 695 transgenic and APOE knockout mice, in Research Advances in Alzheimer's Disease and Related Disorders, pp. 405-414. John Wiley and Son, New York.
19. Mathur C., Prasad V., Raju V., Welch M., and Lieberman S. (1993) Steroids and their conjugates in the mammalian brain. Proc. Natl. Acad. Sci. USA 90, 85-88.
20. Matsuo M., Hamasaki Y., Fujiyama F., and Miyazaki S. (1995) Eicosanoids are produced by microglia, not by astrocytes, in rat glial cell cultures. Brain Res. 685, 201-204.
21. McConathy W. J. and Alaupovic P. (1973) Isolation and partial characterization of apolipoprotein D; a new protein moiety of the human plasma lipoprotein system. FEBS Lett. 37, 178-182.
22. Merched A., Blain H., Visvikis S., Herbeth B., Jeandel C., and Siest G. (1996) Cerebrospinal fluid apolipoprotein E level is increased in late-onset Alzheimer's disease. J. Neurol. Sci. 5146, 33-39.
23. Nalbantoglu J., Gilfix B. M., Bertrand P., Robitaille Y., Gauthier S., Rosenblatt D. S., and Poirier J. (1994) Predictive value of apolipoprotein E genotyping in Alzheimer's disease: results of an autopsy series and an analysis of several combined studies. Ann. Neurol. 36, 889-895.
24. Namba Y., Tomonaga M., and Kawasaki H. (1991) Apolipoprotein E reactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease. Brain Res. 541, 163-166.
25. Neville D. M. (1971) Molecular weight determination of protein dodecyl sulfate complexes by gel electrophoresis in a discontinuous buffer system. J. Biol. Chem. 246, 6328-6334.
26. Ong W. Y., He Y., Suresh S., and Patel S. C. (1997) Differential expression of apolipoprotein D and apolipoprotein E in the kainic acid-lesioned rat hippocampus. Neuroscience 79, 359-367.
27. Patel S. C., Asotra K., Patel Y., McConathy W. J., Patel R. C., and Suresh S. (1995) Astrocytes synthesize and secrete the lipophilic ligand carrier apolipoprotein D. Neuroreport 6, 653-657.
28. Pearlman W. H., Gueriguian J. L., and Sawyer M. E. (1973) A specific progesterone-binding component of human breast cyst fluid. J. Biol. Chem. 248, 5736-5741.
29. Peitsch M. C. and Boguski M. S. (1989) Is apolipoprotein D a mammalian bilin-binding protein? New Biologist 2, 197-206.
30. Pirttila T., Mehta P., Lehtimaki T., Kim K., Sersen E., Frey H., Nikkari T., and Wisniewski H. (1994) Relationship between apolipoprotein E4 allele and CSF amyloid β-protein in Alzheimer's disease and controls. Neurosci. Res. Commun. 15, 201-207.
31. Poirier J., Davignon J., Bouthillier D., Kogan S., Bertrand P., and Gauthier S. (1993) Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 342, 697-699.
32. Popko B., Goodrum J. F., Bouldin T. W., Zhang S. H., and Maeda N. (1993) Nerve regeneration occurs in the absence of apolipoprotein E in mice. J. Neurochem. 60, 1155-1158.
33. Provost P. R., Weech P. K., Tremblay N. M., Marcel Y. L., and Rassart E. (1990) Molecular characterization and differential mRNA tissue distribution of rabbit apolipoprotein D. J. Lipid Res. 31, 2057-2065.
34. Provost P. R., Marcel Y. L., Milne R. W., Weech P. K., and Rassart E. (1991a) Apolipoprotein D transcription occurs specifically in nonproliferating quiescent and senescent fibroblast cultures. FEBS Lett. 290, 139-141.
35. Provost P. R., Villeneuve L., Weech P. K., Milne R. W., Marcel Y. L., and Rassart E. (1991b) Localization of the major sites of rabbit apolipoprotein D gene transcription by in situ hybridization. J. Lipid Res. 32, 1959-1970.
36. Roses A., Saunders A., Corder E., Pericak-Vance S., Han S., Einstein G., Hulette C., Schmechel D., Holsti M., Huang D., Risch N., Haines J., Goedert M., Jakes R., Dong L., Weisgraber K., and Strittmatter W. (1995) Influence of the susceptibility genes apolipoprotein E4 and apolipoprotein E2 on the rate of disease expressivity of late-onset Alzheimer disease. Drug Res. 45, 413-417.
37. Saunders A., Strittmatter W., Schmechel D., St. George-Hyslop P. H., Pericak-Vance M. A., Joo S. H., Rosi B. L., Gusella J. F., Crapper-MacLachlan D. R., Alberts M. J., Hulette C., Crain B., Goldgaber D., and Roses A. D. (1993) Association of apolipoprotein E allele E4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43, 1467-1472.
38. Séguin D., Desforges M., and Rassart E. (1995) Molecular characterization and differential mRNA tissue distribution of mouse apolipoprotein D. Mol. Brain Res. 30, 242-250.
39. Simard J., Dauvois S., Haagensen D. E., Levesque C., Merand Y., and Labrie F. (1990) Regulation of progesterone-binding breast cyst protein GCDFP-24 secretion by estrogens and androgens in human breast cancer cells: a new marker of steroid action in breast cancer. Endocrinology 126, 3223-3231.
40. Simard J., de Launoit Y., Haagensen D. E., and Labrie F. (1992) Additive stimulatory action of glucocorticoids and androgens on basal and estrogen-repressed apolipoprotein-D messenger ribonucleic acid levels and secretion in human breast cancer cells. Endocrinology 130, 1115-1121.
41. Smith K., Lawn R., and Wilcox J. (1990) Cellular localization of apolipoprotein D and lecithin:cholesterol acyltransferase mRNA in rhesus monkey tissues by in situ hybridization. J. Lipid Res. 31, 995-1004.
42. Spreyer P., Schaal H., Kuhn G., Rothe T., Unterbeck A., Oleck K., and Muller H.W. (1990) Regeneration-associated high level expression of apolipoprotein D mRNA in endoneurial fibroblasts of peripheral nerve. EMBO J. 9, 2479-2484.
43. St.-Clair D., Norrman R., Perry R., Yates C., Wilcock G., and Brookes A. (1994) Apolipoprotein E4 allele frequency in patients with Lewy-body dementia, Alzheimer's disease and age-matched controls. Neurosci. Lett. 176, 45-46.
44. Steyer E. and Kostner K. M. (1988) Activation of lecithin-cholesterol acyltransferase by apolipoprotein D: comparison of proteoliposomes containing apolipoprotein D, A-I or C-I. Biochim. Biophys. Acta 958, 484-491.
45. Strittmatter W., Saunders A., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G. S., and Roses A. D. (1993) Apolipoprotein E: high-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease. Proc. Natl. Acad. Sci. USA 90, 1977-1988.
46. Weech P. K., Camato R., Milne R. W., and Marcel Y. L. (1986) Apolipoprotein D and cross-reacting human plasma apolipoproteins identified using monoclonal antibodies. J. Biol. Chem. 261, 7941-7951.
47. Weisgraber K. H., Rall S. C. Jr., Mahley R. W., Milne R. W., Marcel Y. L., and Sparrow J. T. (1986) Human apolipoprotein E: determination of the heparin binding sites of apolipoprotein E3. J. Biol. Chem. 261, 2068-2076.
48. Weisgraber K. H., Pitas R. E., and Mahley R. W. (1994) Lipoproteins, neurobiology, and Alzheimer's disease: structure and function of apolipoprotein E. Curr. Opin. Struct. Biol. 4, 507-515.
49. Wisniewski T., Golabeck A., Matsubara E., Ghiso J., and Frangione B. (1993) Apolipoprotein E: binding to soluble Alzheimer's β-amyloid. Biochem. Biophys. Res. Commun. 192, 359-365.
50. Zubenko G., Stiffler S., Stabler S., Kopp U., Hughes H., Cohen B., and Moossy J. (1994) Association of the apolipoprotein E4 allele with clinical subtypes of autopsy-confirmed Alzheimer's disease. Am. J. Med. Genet. 54, 199-205.